|
"tseng js"的相关文件
显示项目 1-19 / 19 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2023-11-01 |
Low-dose computed tomography screening in relatives with a family history of lung cancer
|
Wang, CL;Hsu, KH;Chang, YH;Ho, CC;Chiang, CJ;Chen, KC;Cheung, YC;Huang, PC;Chen, YR;Chen, CY;Hsu, CP;Hsia, JY;Chen, HY;Yang, SY;Li, YJ;Yang, TY;Tseng, JS;Chuang, CY;Hsiung, CA;Chen, YM;Huang, MS;Yu, CJ;Chen, KY;Su, WC;Chen, J;Yu, SL;Chen, CJ;Yang, PC;Tsai, YH;Chang, GC |
| 國家衛生研究院 |
2023-07-04 |
Low-dose CT screening in relatives with a family history of lung cancer
|
Wang, CL;Hsu, KH;Chang, YH;Ho, CC;Chiang, CJ;Chen, KC;Cheung, YC;Huang, PC;Chen, YR;Chen, CY;Hsu, CP;Hsia, JY;Chen, HY;Yang, SY;Li, YJ;Yang, TY;Tseng, JS;Chuang, CY;Hsiung, CA;Chen, YM;Huang, MS;Yu, CJ;Chen, KY;Su, WC;Chen, JJW;Yu, SL;Chen, CJ;Yang, PC;Tsai, YH;Chang, GC |
| 國家衛生研究院 |
2023-02-28 |
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
|
Lee, PH;Chiang, CJ;Tseng, JS;Zheng, ZR;Chen, KC;Chu, CH;Huang, YH;Hsu, KH;Lee, WC;Yang, TY;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2022-03-01 |
Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018
|
Tseng, JS;Chiang, CJ;Chen, KC;Zheng, ZR;Yang, TY;Lee, WC;Hsu, KH;Huang, YH;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee, PH;Yang, TY;Chen, KC;Huang, YH;Tseng, JS;Hsu, KH;Wu, YC;Liu, KJ;Chang, GC |
| 中山醫學大學 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC |
| 中山醫學大學 |
2021 |
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study
|
Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response
|
Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC |
| 中山醫學大學 |
2021 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, YH; Tseng, JS; Hsu, KH; Chen, KC; Su, KY; Yu, SL; Chen, JJW; Yang, TY; Chang, GC |
| 中山醫學大學 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
|
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
| 中山醫學大學 |
2020 |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, GC; Yang, TY; Chen, KC; Hsu, KH; Huang, YH; Su, KY; Yu, SL; Tseng, JS |
| 中山醫學大學 |
2020 |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
|
Raghav, L; Chang, YH; Hsu, YC; Li, YC; Chen, CY; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chuang, CY; Lee, MH; Wang, CL; Chen, HW; Yu, SL; Su, SF; Yuan, SS; Chen, JJW; Ho, SY; Li, KC; Yang, PC; Chang, GC; Chen, HY |
| 國家衛生研究院 |
2019-01-18 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan
|
Tseng, CH;Tsuang, BJ;Chiang, CJ;Ku, KC;Tseng, JS;Yang, TY;Hsu, KH;Chen, KC;Yu, SL;Lee, WC;Liu, TW;Chan, CC;Chang, GC |
| 國家衛生研究院 |
2017-10-12 |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng, CH;Chiang, CJ;Tseng, JS;Yang, TY;Hsu, KH;Chen, KC;Wang, CL;Chen, CY;Yen, SH;Tsai, CM;Huang, MS;Ho, CC;Yu, CJ;Tsai, YH;Chen, JS;Chou, TY;Tsai, MH;Chen, HY;Su, KY;Chen, JJW;Chen, HW;Yu, SL;Liu, TW;Chang, GC |
| 國家衛生研究院 |
2016-07 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, CH;Tseng, CH;Chiang, CJ;Hsu, KH;Tseng, JS;Chen, KC;Wang, CL;Chen, CY;Yen, S;Chiu, CH;Huang, MS;Yu, CJ;Tsai, YH;Chen, JS;Tsai, CM;Chou, TY;Lin, KC;Tsai, MH;Lee, WC;Ku, HY;Liu, TW;Yang, TY;Chang, GC |
| 國家衛生研究院 |
2015-07 |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen, HY;Yu, SL;Ho, BC;Su, KY;Hsu, YC;Chang, CS;Li, YC;Yang, SY;Hsu, PY;Ho, H;Chang, YH;Chen, CY;Yang, HI;Hsu, CP;Yang, TY;Chen, KC;Hsu, KH;Tseng, JS;Hsia, JY;Chuang, CY;Yuan, S;Lee, MH;Liu, CH;Wu, GI;Hsiung, CA;Chen, YM;Wang, CL;Huang, MS;Yu, CJ;Chen, KY;Tsai, YH;Su, WC;Chen, HW;Chen, JJ;Chen, CJ;Chang, GC;Yang, PC;Li, KC |
| 臺北醫學大學 |
1999 |
大型醫院資料庫系統效能調校方法與實務.
|
劉建財; Liu CT; Huang CM; Tseng JS |
显示项目 1-19 / 19 (共1页)
1
每页显示[10|25|50]项目
|
